Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 9Lung Neoplasms 6Pain, Postoperative 3Urinary Bladder Neoplasms 2Male Urogenital Diseases 2Inflammatory Bowel Diseases 2Inflammation 2Diverticulitis 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Agnosia 2Abdominal Cancer 2Unspecified Adult Solid Tumor, Protocol Specific 1Smoking Cessation 1Skin Neoplasms 1Shoulder Pain 1Respiration Disorders 1Post-thoracotomy Pain Syndrome 1Pleural Diseases 1Pancreatic Neoplasms 1Neoplasms 1Mouth Neoplasms 1Lung Cancer Prevention 1Liver Neoplasms 1Incident Breast Cancer 1Immunity Factors in Cancer Colon Patients 1Gynecologic Surgical Procedures 1Condylomata Acuminata 1Colorectal Neoplasms 1Chronic Pain 1

Interventions

padeliporfin 4Lycopene 3Vitamin E 2Tea 2Selenium 2Cholecalciferol 2Therapeutics 1Sugars 1Intraoperative Neurophysiological Monitoring 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Male Urogenital Diseases × Tea × Clear all
NCT00744549 2018-02-14

Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance

University Health Network, Toronto

Phase 2 Completed
16 enrolled
Genitourinary

Prostatic Neoplasms, Male Urogenital Diseases

NCT00844792 2017-10-26

Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer

University Health Network, Toronto

Phase 2 Completed
48 enrolled
Genitourinary

Prostatic Neoplasms, Male Urogenital Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡